Cardiovascular Systems ROA 2006-2018 | CSII

Current and historical return on assets (ROA) values for Cardiovascular Systems (CSII) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Cardiovascular Systems ROA for the three months ending September 30, 2018 was 0.41%.
Cardiovascular Systems ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.00B $0.20B 0.51%
2018-06-30 $0.00B $0.20B 1.03%
2018-03-31 $-0.00B $0.20B -0.52%
2017-12-31 $-0.00B $0.19B -1.58%
2017-09-30 $-0.00B $0.19B -1.10%
2017-06-30 $-0.00B $0.19B -1.18%
2017-03-31 $-0.01B $0.19B -5.11%
2016-12-31 $-0.03B $0.16B -19.86%
2016-09-30 $-0.05B $0.14B -31.25%
2016-06-30 $-0.06B $0.14B -37.33%
2016-03-31 $-0.06B $0.15B -38.16%
2015-12-31 $-0.05B $0.15B -28.96%
2015-09-30 $-0.04B $0.16B -21.93%
2015-06-30 $-0.03B $0.17B -18.51%
2015-03-31 $-0.03B $0.18B -18.78%
2014-12-31 $-0.03B $0.18B -18.08%
2014-09-30 $-0.04B $0.18B -20.27%
2014-06-30 $-0.04B $0.18B -22.40%
2014-03-31 $-0.03B $0.19B -23.66%
2013-12-31 $-0.03B $0.18B -24.58%
2013-09-30 $-0.03B $0.10B -29.89%
2013-06-30 $-0.02B $0.10B -30.67%
2013-03-31 $-0.02B $0.10B -31.54%
2012-12-31 $-0.02B $0.06B -34.78%
2012-09-30 $-0.02B $0.06B -32.00%
2012-06-30 $-0.02B $0.06B -31.92%
2012-03-31 $-0.01B $0.05B -28.43%
2011-12-31 $-0.01B $0.05B -25.13%
2011-09-30 $-0.01B $0.05B -21.74%
2011-06-30 $-0.01B $0.05B -22.47%
2011-03-31 $-0.01B $0.04B -27.59%
2010-12-31 $-0.02B $0.05B -35.42%
2010-09-30 $-0.02B $0.04B -41.71%
2010-06-30 $-0.02B $0.04B -40.17%
2010-03-31 $-0.03B $0.06B -38.81%
2009-12-31 $0.00B $0.06B 4.26%
2009-09-30 $0.01B $0.07B 18.35%
2009-06-30 $0.00B $0.07B 4.00%
2009-03-31 $-0.01B $0.08B -34.38%
2008-12-31 $-0.06B $0.00B -174.44%
2008-09-30 $-0.06B $0.05B -174.44%
2008-06-30 $-0.06B $0.00B -119.15%
2008-03-31 $0.01B $0.08B 10.49%
2007-12-31 $0.02B $0.00B 27.43%
2007-09-30 $0.02B $0.11B 27.43%
2007-06-30 $0.03B $0.12B 31.09%
2007-03-31 $-0.02B $0.13B -25.60%
2006-12-31 $-0.03B $0.00B -40.16%
2006-09-30 $-0.04B $0.14B -48.56%
2006-06-30 $-0.04B $0.11B -98.82%
2006-03-31 $-0.04B $0.00B -256.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.046B $0.217B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.111B 19.18
Abbott Laboratories (ABT) United States $123.927B 25.11
Stryker (SYK) United States $63.616B 23.98
Boston Scientific (BSX) United States $51.104B 25.83
Baxter (BAX) United States $32.759B 21.16
Zimmer Biomet Holdings (ZBH) United States $23.343B 15.14
Smith & Nephew SNATS (SNN) United Kingdom $15.929B 0.00
ResMed (RMD) United States $14.783B 28.19
Canopy Growth (CGC) Canada $9.096B 0.00
Perrigo (PRGO) Ireland $8.909B 13.52
Bio-Rad Laboratories (BIO) United States $8.086B 51.70
Aurora Cannabis (ACB) Canada $6.688B 36.63
Hill-Rom Holdings (HRC) United States $6.277B 19.90
Haemonetics (HAE) United States $5.440B 47.85
Insulet (PODD) United States $4.849B 0.00
ICU Medical (ICUI) United States $4.490B 25.04
Hutchison China MediTech (HCM) China $4.221B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.051B 0.00
Agios Pharmaceuticals (AGIO) United States $3.732B 0.00
Neogen (NEOG) United States $3.281B 49.69
National Vision Holdings (EYE) United States $3.207B 70.82
NuVasive (NUVA) United States $2.954B 27.49
Aphria (APHA) $2.817B 0.00
Quidel (QDEL) United States $2.479B 32.31
NxStage Medical (NXTM) United States $1.925B 0.00
Phibro Animal Health (PAHC) United States $1.446B 20.47
AtriCure (ATRC) United States $1.192B 0.00
VAREX IMAGING (VREX) United States $1.018B 16.63
PetIQ (PETQ) United States $0.849B 27.76
Meridian Bioscience (VIVO) United States $0.828B 26.38
OraSure Technologies (OSUR) United States $0.826B 46.52
Surmodics (SRDX) United States $0.787B 120.33
Eagle Pharmaceuticals (EGRX) United States $0.753B 24.16
Cerus (CERS) United States $0.715B 0.00
MacroGenics (MGNX) United States $0.702B 0.00
Omeros (OMER) United States $0.628B 0.00
Owens & Minor (OMI) United States $0.575B 6.50
Lantheus Holdings (LNTH) United States $0.572B 17.69
Insys Therapeutics (INSY) United States $0.548B 0.00
LeMaitre Vascular (LMAT) United States $0.526B 25.81
NanoString Technologies (NSTG) United States $0.455B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.401B 0.00
Quanterix (QTRX) United States $0.362B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.99
Cytosorbents (CTSO) United States $0.306B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.214B 289.75
Bovie Medical (BVX) United States $0.204B 0.00
Rockwell Medical (RMTI) United States $0.201B 0.00
Chimerix (CMRX) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.156B 0.00
Fonar (FONR) United States $0.141B 7.11
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.67
InfuSystems Holdings (INFU) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00